• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用替代标志物进行治疗效果的分组序贯检验。

Group sequential testing of a treatment effect using a surrogate marker.

机构信息

Department of Statistics and Data Sciences, The University of Texas at Austin, Austin, TX 78712, United States.

出版信息

Biometrics. 2024 Oct 3;80(4). doi: 10.1093/biomtc/ujae108.

DOI:10.1093/biomtc/ujae108
PMID:39377516
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11459368/
Abstract

The identification of surrogate markers is motivated by their potential to make decisions sooner about a treatment effect. However, few methods have been developed to actually use a surrogate marker to test for a treatment effect in a future study. Most existing methods consider combining surrogate marker and primary outcome information to test for a treatment effect, rely on fully parametric methods where strict parametric assumptions are made about the relationship between the surrogate and the outcome, and/or assume the surrogate marker is measured at only a single time point. Recent work has proposed a nonparametric test for a treatment effect using only surrogate marker information measured at a single time point by borrowing information learned from a prior study where both the surrogate and primary outcome were measured. In this paper, we utilize this nonparametric test and propose group sequential procedures that allow for early stopping of treatment effect testing in a setting where the surrogate marker is measured repeatedly over time. We derive the properties of the correlated surrogate-based nonparametric test statistics at multiple time points and compute stopping boundaries that allow for early stopping for a significant treatment effect, or for futility. We examine the performance of our proposed test using a simulation study and illustrate the method using data from two distinct AIDS clinical trials.

摘要

替代标志物的鉴定是出于其能够更早地对治疗效果做出决策的潜力。然而,实际上很少有方法被开发出来,以实际使用替代标志物来检验未来研究中的治疗效果。大多数现有的方法考虑结合替代标志物和主要结局信息来检验治疗效果,依赖于充分的参数方法,对替代标志物和结局之间的关系做出严格的参数假设,并且/或者假设替代标志物仅在一个时间点进行测量。最近的工作提出了一种仅使用单一时间点的替代标志物信息的非参数治疗效果检验方法,通过借鉴先前研究中的信息,该研究同时测量了替代标志物和主要结局。在本文中,我们利用这种非参数检验方法,并提出了群组序贯程序,允许在替代标志物随着时间重复测量的情况下,提前停止治疗效果检验。我们在多个时间点推导了相关替代标志物的非参数检验统计量的性质,并计算了允许提前停止治疗效果有意义或无效的停止边界。我们使用模拟研究来检验我们提出的检验方法的性能,并使用来自两个不同的艾滋病临床试验的数据来说明该方法。

相似文献

1
Group sequential testing of a treatment effect using a surrogate marker.使用替代标志物进行治疗效果的分组序贯检验。
Biometrics. 2024 Oct 3;80(4). doi: 10.1093/biomtc/ujae108.
2
Using a surrogate marker for early testing of a treatment effect.使用替代标志物进行治疗效果的早期检测。
Biometrics. 2019 Dec;75(4):1253-1263. doi: 10.1111/biom.13067. Epub 2019 Apr 22.
3
Evaluating surrogate marker information using censored data.使用删失数据评估替代标志物信息。
Stat Med. 2017 May 20;36(11):1767-1782. doi: 10.1002/sim.7220. Epub 2017 Jan 15.
4
A General Framework to Assess Complex Heterogeneity in the Strength of a Surrogate Marker.评估替代标志物强度中复杂异质性的通用框架。
Stat Med. 2025 Feb 28;44(5):e70001. doi: 10.1002/sim.70001.
5
Robust estimation of the proportion of treatment effect explained by surrogate marker information.由替代标志物信息所解释的治疗效果比例的稳健估计。
Stat Med. 2016 May 10;35(10):1637-53. doi: 10.1002/sim.6820. Epub 2015 Dec 2.
6
Evaluation of longitudinal surrogate markers.纵向替代标志物的评估。
Biometrics. 2021 Jun;77(2):477-489. doi: 10.1111/biom.13310. Epub 2020 Jun 22.
7
Assessing heterogeneity in surrogacy using censored data.使用删失数据评估代孕中的异质性。
Stat Med. 2024 Jul 30;43(17):3184-3209. doi: 10.1002/sim.10122. Epub 2024 May 29.
8
Using a surrogate with heterogeneous utility to test for a treatment effect.使用具有异质效用的替代指标来检验治疗效果。
Stat Med. 2023 Jan 15;42(1):68-88. doi: 10.1002/sim.9602. Epub 2022 Nov 13.
9
Testing for heterogeneity in the utility of a surrogate marker.检测替代标志物效用的异质性。
Biometrics. 2023 Jun;79(2):799-810. doi: 10.1111/biom.13600. Epub 2021 Dec 7.
10
Robust methods to correct for measurement error when evaluating a surrogate marker.稳健的方法来纠正替代标志物评估中的测量误差。
Biometrics. 2022 Mar;78(1):9-23. doi: 10.1111/biom.13386. Epub 2020 Oct 16.

引用本文的文献

1
Surrogate Marker Evaluation: A Tutorial Using R.替代标志物评估:使用R语言的教程
Stat Med. 2025 May;44(10-12):e70048. doi: 10.1002/sim.70048.

本文引用的文献

1
Incorporating Covariates into Measures of Surrogate Paradox Risk.将协变量纳入替代悖论风险度量中。
Stats (Basel). 2023 Mar;6(1):322-344. doi: 10.3390/stats6010020. Epub 2023 Feb 17.
2
Utilization of treatment effect on a surrogate endpoint for planning a study to evaluate treatment effect on a final endpoint.利用替代终点的治疗效果来规划一项评估最终终点治疗效果的研究。
Pharm Stat. 2023 Jul-Aug;22(4):633-649. doi: 10.1002/pst.2298. Epub 2023 Mar 3.
3
Using a surrogate with heterogeneous utility to test for a treatment effect.使用具有异质效用的替代指标来检验治疗效果。
Stat Med. 2023 Jan 15;42(1):68-88. doi: 10.1002/sim.9602. Epub 2022 Nov 13.
4
A Review of Domain Adaptation without Target Labels.无目标标签的领域自适应综述
IEEE Trans Pattern Anal Mach Intell. 2021 Mar;43(3):766-785. doi: 10.1109/TPAMI.2019.2945942. Epub 2021 Feb 4.
5
Using a surrogate marker for early testing of a treatment effect.使用替代标志物进行治疗效果的早期检测。
Biometrics. 2019 Dec;75(4):1253-1263. doi: 10.1111/biom.13067. Epub 2019 Apr 22.
6
Predictive probability of success using surrogate endpoints.使用替代终点预测成功率。
Stat Med. 2019 May 10;38(10):1753-1774. doi: 10.1002/sim.8060. Epub 2018 Dec 12.
7
Estimation of the optimal surrogate based on a randomized trial.基于随机试验的最佳替代指标估计。
Biometrics. 2018 Dec;74(4):1271-1281. doi: 10.1111/biom.12879. Epub 2018 Apr 27.
8
Evaluating surrogate marker information using censored data.使用删失数据评估替代标志物信息。
Stat Med. 2017 May 20;36(11):1767-1782. doi: 10.1002/sim.7220. Epub 2017 Jan 15.
9
Surrogacy marker paradox measures in meta-analytic settings.荟萃分析环境中的替代标志物悖论测量
Biostatistics. 2015 Apr;16(2):400-12. doi: 10.1093/biostatistics/kxu043. Epub 2014 Sep 17.
10
Surrogate measures and consistent surrogates.替代指标与一致性替代指标
Biometrics. 2013 Sep;69(3):561-9. doi: 10.1111/biom.12071.